Ubs Group Ag Renovo Rx, Inc. Transaction History
Ubs Group Ag
- $555 Billion
- Q2 2025
A detailed history of Ubs Group Ag transactions in Renovo Rx, Inc. stock. As of the latest transaction made, Ubs Group Ag holds 30,009 shares of RNXT stock, worth $33,009. This represents 0.0% of its overall portfolio holdings.
Number of Shares
30,009
Previous 66,732
55.03%
Holding current value
$33,009
Previous $66,000
40.91%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding RNXT
# of Institutions
28Shares Held
9.77MCall Options Held
0Put Options Held
0-
Aigh Capital Management LLC Baltimore, MD3.47MShares$3.81 Million2.59% of portfolio
-
Awm Investment Company, Inc. New York, NY1.87MShares$2.06 Million0.35% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.66MShares$1.83 Million0.0% of portfolio
-
Bank Of The West975KShares$1.07 Million0.27% of portfolio
-
Bleichroeder LP New York, NY500KShares$550,0000.21% of portfolio
About RenovoRx, Inc.
- Ticker RNXT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 9,066,860
- Market Cap $9.97M
- Description
- RenovoRx, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapies for the treatment of solid tumors. Its lead product candidate is RenovoGem, a drug and device combination consisting of intra-arterial gemcitabine and RenovoCath that is in Phase III clinical trials for the locally advanced pancreatic cancer. RenovoRx, In...